Effective inhibition of tumor in vivo with a novel DNA vaccine targeting chimeric G250.
CONCLUSIONS: The experimental results of this study exhibited that the DNA vaccine based on heterogeneous chimeric antigen can produce efficient anti-tumor effect in vivo and they represent a promising strategy for tumor immunotherapy.
PMID: 32706085 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Allergy & Immunology | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Genetics | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Study | Vaccines